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Abstract
Background We aimed to study the impact of obesity on uri-
nary excretion of angiotensinogen (U-AGT) in prepubertal
children, focusing on the duration of obesity and gender.
Also, we aimed to evaluate whether plasma angiotensinogen
(P-AGT) and hydrogen peroxide (H2O2) play a role in the
putative association.
Methods Cross-sectional evaluation of 305 children aged 8–
9 years (160 normal weight, 86 overweight, and 59 obese).
Anthropometric measurements and 24-h ambulatory blood
pressure monitoring were performed. Angiotensinogen
(AGT) was determined by a commercial enzyme-linked im-
munosorbent assay (ELISA) kit and H2O2 by a microplate
fluorometric assay.
Results U-AGT and P-AGT levels were similar across body
mass index (BMI) groups and between sexes. However,
boys who were overweight/obese since the age of 4 years
presented lower levels of U-AGT compared with those of
normal weight at the same age. In children who were
overweight/obese since the age of 4, urinary H2O2 decreased
with P-AGT.
Conclusions A higher duration of obesity was associated with
decreased U-AGT in boys, thus reflecting decreased intrarenal
activity of the renin–angiotensin system. Also, children with a
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longer duration of obesity showed an inverse association be-
tween urinary H2O2 and P-AGT. Future studies should ad-
dress whether these results reflect an early compensatory
mechanism to limit obesity-triggered renal dysfunction.
Keywords Angiotensinogen . Obesity . Overweight . Body
mass index . Children . Hydrogen peroxide
Introduction
The prevalence of childhood obesity has tripled in the last
three decades, reaching epidemic proportions around the
world [1]. Even at younger ages, obesity triggers a cascade
of metabolic changes that contribute to the development of
hypertension, diabetes, atherosclerosis, and chronic renal dis-
ease [2, 3]. Besides, obesity in childhood and adolescence
predicts the risk of cardiovascular morbidity and premature
mortality in adults [4]. The mechanisms underlying the asso-
ciation between a high body mass index (BMI) in childhood
and adolescence and cardiovascular and kidney disease in
adulthood are not well characterized, and no biomarkers are
available for use in routine clinical practice to allow early
identification of high-risk children.
The renin–angiotensin–aldosterone system (RAAS) has
been implicated in the harmful consequences of obesity.
This well-coordinated hormonal system regulates cardiovas-
cular and renal function by controlling fluid and electrolyte
homeostasis. Furthermore, tissue RAAS exists in specific tis-
sues, namely the kidney and adipose tissue [5]. In the adipose
tissue, RAAS components are highly expressed and secreted
by mature adipocytes [6–8], although contradictory findings
have been reported regarding its regulation in obese condi-
tions. Some studies report an increased expression [6] and
secretion [5, 9] of adipose tissue-derived RAAS components
in obese individuals that might contribute to activate systemic
RAAS and potentiate its deleterious effects [6, 8, 10, 11].
Other studies describe reduced expression of angiotensinogen
(AGT) in adipose tissue that parallels the time course of adi-
pocyte hypertrophy, which is tightly associated with the pro-
gression of obesity [12].
Childhood obesity is also associated with renal injury, and
the kidney is particularly vulnerable to the effects of the
RAAS, both through the hemodynamic impact of systemic
RAAS activation and by local intrarenal activation, mostly
derived from AGT produced in the proximal tubule [7, 13].
Urinary excretion of AGT (U-AGT) has been validated as a
noninvasive biomarker of intrarenal RAAS activity [13] and
increased U-AGT has been found in human hypertension,
diabetes, and renal disease [13] even in adolescents [14, 15]
and children [16]. The rise in U-AGT precedes the onset of
microalbuminuria, suggesting that U-AGT might be an early
marker of nephropathy [15]. Interestingly, excessive
activation of the adipose RAAS seems to be crucial for estab-
lishment and progression of kidney disease [13, 17] but only
two small sample studies have been performed in the setting
of human obesity [7, 18]. In both studies, no difference was
found in U-AGT between obese adults and nonobese controls.
Remarkably, it was recently highlighted that not only severity
but also duration of obesity can determine obesity-related tar-
get-organ lesions [19, 20] but neither of those studies took that
in consideration. Also, the study of Thethi et al. showed that
obese women had higher U-AGT than obese men, although
there was no gender difference in the nonobese group [7].
Gender is known to influence blood pressure (BP) and cardio-
vascular and renal functions, and evidence implies that the
RAAS might be a putative link in this association [21].
These data raise the possibility of gender differences in the
association between RAAS and obesity.
The deleterious effects of intrarenal RAAS are due, at least
in part, to potentiation of angiotensin II (Ang II)-mediated
renal effects [2, 7], namely the production of reactive oxygen
species and cytokines and the stimulation of cell growth, in-
flammation and fibrosis [13, 22]. Hydrogen peroxide (H2O2),
a nonradical oxidant and a known mediator of Ang II effects
[23], also appears to be involved in the regulation of RAAS
components. Recent experimental studies suggest that H2O2
increases AGTexpression in the kidney but induces its down-
regulation in adipose tissue [12, 24–26]. However, this rela-
tionship between H2O2 and AGT has not yet been explored in
humans.
We aimed at characterizing the impact of obesity on U-
AGT in prepubertal, otherwise healthy, children. We com-
pared U-AGT between normal weight, overweight, and obese
children and evaluated whether gender or obesity duration
influence the putative association between obesity and U-
AGT at this age. Furthermore, since experimental evidence
indicates H2O2 as a modulator of AGT expression both in
kidney and adipose tissue [12, 24–26], we evaluated the link
between urinary excretion of H2O2 (U-H2O2), U-AGT, and
plasma AGT (P-AGT) levels.
Methods
Study design and sample collection
We conducted a cross-sectional study of children aged 8–
9 years followed since birth in a previously established
Portuguese cohort study (Generation XXI) [27]. Children
from the original cohort (n = 8647 newborns) were eligible
for the ObiKid project if they had anthropometric data and a
blood sample withdrawn at the study site in the 7-year-old
evaluation (Fig. 1; n = 4590). For the Obikid project [28],
we wanted to include a minimum sample of 300 children,
since this sample size would provide a statistical power of
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85% with a significance level of 0.05 to detect a difference in
estimated glomerular filtration rate (eGFR) of at least 8 ml/
min/1.73 m2 between normal weight and overweight/obese
children, assuming a standard deviation (SD) of 24 and
1253 refused blood withdrawal
2 without blood sample (plasma or serum)
12 without urine sample (24h or random spot)
5 without ABPM analysis
324 children evaluated in the ObiKid Project
Pre-selecon of 463 children to be included in the ObiKid project
(Consecuve sample of the list of eligible children at 7 years evaluaon children – date of evaluaon)
305 children with complete informaon (present study)
8647 newborns included in the Generaon XXI cohort
Ineligible at 7 years
132 refused to parcipate at 4 years evaluaon
18 deceased
8497 children eligible for 7 years evaluaon
379 refused to parcipate 
2 deceased
469 could not be contacted (Requested callback but not 
reached…)
713 no working telephone or acve contact
5843 children evaluated at 7 years by face-to-face interview 
31 refused to parcipate + 1 instuonalized
51 live >30km from Porto
16 could not be contacted (No acve contact/no answer)
23 not evaluated
Exclusion criteria:
6 children with twins (12 children excluded)
4 chronic disease
1 chronic medicaon 
1040 evaluated by phone interview
45 refused the telephone interview
6 evaluated by face-to-face interview in domiciliary visit
4590 children with blood analysis at 7 years – eligible for the ObiKid project
Fig. 1 Patient inclusion
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22 ml/min/1.73 m2 in each group, respectively [29]. We as-
sumed that a minimum of 35% of children would be excluded
due to refusal to participate, exclusion criteria, or incomplete
information. We needed to consecutively screen and attempt
to contact 463 children from the 4590 eligible ones to obtain
the required sample; 16 could not be contacted, 32 refused to
participate, 23 were unable to schedule study visits during the
recruitment period, and 68met exclusion criteria [four chronic
diseases (genetic, renal, or metabolic), one chronic usage of
medication (affecting BP, glucose, or lipid metabolism), 51
living far from the study site, and 12 twins]. Participants with
acute illness, namely febrile conditions, were asked to post-
pone the scheduled study visit for a period of at least 15 days
after total recovery. We finally enrolled 324 participants, but
for our analysis 19 were excluded due to absence of adequate
blood or urine samples or missing values in variables of inter-
est. Our study therefore assessed 305 children (Fig. 1). No
significant differences were found between included and eli-
gible children with respect to sex, weight, height, systolic/
diastolic BP, and parental education level at the follow-up visit
at 7 years of age.
Data collection and variable definition
The study visits took place at the Department of Clinical
Epidemiology, Predictive Medicine and Public Health,
Faculty of Medicine, University of Porto. Data on birth and
neonatal characteristics were abstracted from clinical records.
Gestational age was considered as determined by ultrasonog-
raphy. Classes of the sex-specific adequate birth weight for
gestational age were defined according to the population-
based Canadian reference curves (<10th percentile = small
for gestational age; ≥10th percentile and <90th percentile =
adequate for gestational age; ≥90th percentile = large for ges-
tational age) [30]. Anthropometric and general physical exam-
inations assessed weight, height, waist circumference and
body composition by bioelectrical impedance analysis (per-
cent body fat mass). Data collection was performed according
to standard procedures and as previously reported [31]. Waist
circumference was indexed to height [waist-to-height ratio
(WHtR) in cm/m] for statistical analysis. BMI-for-age values
were classified according to the World Health Organization
(WHO) growth reference data for BMI z-score into the fol-
lowing categories: normal weight (−2 SD to +1 SD); over-
weight (> +1 SD), and obesity (> + 2 SD) [32]. To evaluate
the effect of duration of obesity on variables studied, we gath-
ered the most recent anthropometric data available from the
previous evaluations of the cohort; accordingly, data at 4 years
of age was gathered and analyzed. At that age, BMI-for-age
values were classified according to the WHO growth refer-
ence data for BMI z-score for children <5 years [33]. Among
overweight/obese children at the age of 8–9 with anthropo-
metric evaluation at the age of 4 (n = 132), two groups were
considered: those known to be overweight or obese since the
age of 4 (n = 88; 39 girls, 49 boys) and those classified as
normal weight at the age of 4 (n = 44; 18 girls, 26 boys).
Ambulatory BP monitoring (ABPM) was performed for
24 h with a portable, noninvasive, oscillometric BP recorder
(Spacelabs Healthcare®, model 90207). The nondominant
arm was used to allow free movement during everyday activ-
ity and reduce measurement errors due to movement artifacts.
Cuff size was chosen according to patient’s arm circumfer-
ence. BP measurements were taken automatically at 20-min
intervals during the day and at 30-min intervals during the
night. A minimum monitoring duration of 24 h with gaps
<2 h was required for acceptance; five of the ABPM analysis
examinations were excluded due to insufficient readings.
Readings were used to calculate mean 24 h, daytime and
nighttime mean arterial (MAP), systolic (SBP) and diastolic
(DBP) pressures, using SpaceLabs® software. SD scores for
BP values were calculated (least mean square method) accord-
ing to the published reference values of the German Working
Group on Pediatric Hypertension [34]. To characterize circa-
dian BP rhythmicity, we calculated the percentage of noctur-
nal fall in MAP using the following formula: [mean daytime
MAP – mean nighttime MAP]/[mean daytime MAP] × 100.
The nondipping pattern was considered when a drop in night-
time MAP <10% of the corresponding daytime BP was
observed.
Laboratory procedures
A venous blood sample was collected from all participants
after an overnight fast of at least 8 h and analyzed for cystatin
C, creatinine, uric acid, aldosterone, and P-AGT. All partici-
pants collected a spot urine sample, which was analyzed for
albumin, creatinine, and U-AGT, and a 24-h urine sample,
which was analyzed for H2O2. All standard laboratory mea-
surements were performed in the Clinical Pathology
Department of Centro Hospitalar São João, Porto, Portugal.
Serum cystatin C was assayed using a particle-enhanced
immunonephelometric assay (N latex Cystatin C,
Siemens®). Serum creatinine assay was based on the Jaffé
compensated traceable to an isotope dilution mass spectrom-
etry method (Olympus AU 5400 automated analyzer,
Beckman-Coulter®, USA). Urinary creatinine and albumin
were determined with the same clinical immunochemistry an-
alyzer. GFR was estimated by the Zappitelli combined formu-
la (in ml/min/1.73 m2) [35]. Aldosterone concentration was
measured using Liaison Aldosterone Kit® (DiaSorin Inc.,
USA) in serum samples. Urinary and plasma concentrations
of AGT and urinary excretion of H2O2 were assessed in the
Department of Pharmacology and Therapeutics of the Faculty
ofMedicine at the University of Porto. AGTwas quantified by
an immunoenzymatic method, using a commercial enzyme-
linked immunosorbent assay (ELISA) kit (Human Total
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Angiotensinogen Assay Kit, Immuno-Biological Laboratories
Co., Gunma, Japan) and H2O2 evaluated using a microplate
fluorometric assay (Amplex Red Hydrogen Peroxide/
Peroxidase Assay Kit, Molecular Probes, Alfagene,
Carcavelos, Portugal), according to protocols provided by
the manufacturers. Data concerning AGTand H2O2 have been
recently used by our group as part of studies on the same
cohort to evaluate the association with urinary fibrogenic cy-
tokines [36] and oxidative stress [37], respectively.
Statistical analysis
Data are presented as mean and SD or, if skewed, as median
and 25th–75th percentiles (P25–P75). U-AGT, P-AGT, and
U-H2O2 had an asymmetric distribution and were
logarithmized (base 10) before linear regression analyzes,
allowing a normal distribution to be obtained. The tertiles of
WHtR, percent of body fat mass, and U-AGT were defined
based on all enrolled participants. Linear trend was tested
using linear regression models with BMI z-score classes and
tertiles of WHtR and body fat mass included as independent
continuous variables and U-AGT (logarithm base 10) as the
dependent variable. Tertiles of P-AGTwere used as indepen-
dent variables and H2O2 (logarithm base 10) as the dependent
variable. Models were additionally adjusted for sex and age
(in months).
Results
A total of 305 children (54% male) with a mean (SD) age of
8.8 (0.2) years were assessed. General characteristics and
levels of biochemical parameters are shown in Tables 1 and
2, respectively, by BMI classes (160 normal weight, 86 over-
weight, and 59 obese children). Overweight and obese chil-
dren had higher birth weight but no differences in distribution
in classes of adequacy of birth weight for gestational age.
Overweight and obese children presented significantly higher
values of 24-h and nighttime MAP values (Table 1).
Regarding analytical parameters, overweight and obese chil-
dren presented higher uric acid, creatinine, and cystatin C
levels and lower eGFR values. No differences were found in
median values of aldosterone, U-albumin, or U-H2O2 across
groups (Table 2).
The levels of U–AGT were not significantly different
across BMI classes (normal weight 5.6 (3.7–7.6); overweight
5.3 (3.4–8.3); obese 4.8 (2.8–7.8) μg/g of creatinine, p =
0.338) and neither were P–AGT levels (normal weight 36.6
(32.4–47.3); overweight 37.3 (32.6–44.8); obese 38.8 (34.1–
44.3) μg/ml, p = 0.780) (Table 2). The distribution of U-AGT
and P-AGT levels by classes of BMI and tertiles ofWHtR and
body fat mass is shown in Fig. 2. Regardless of the obesity
index considered, no significant differences were found in the
linear trend analysis of U-AGT or P-AGT levels (Fig. 2).
No differences were found between sexes in median P-
AGT [38.5 (33.6–46.2) vs. 36.3 (31.7–43.4) μg/ml, p =
0.069, in girls and boys, respectively] or U-AGT [5.1 (2.8–
8.5) vs. 5.5 (3.7–7.3) μg/g of creatinine, p = 0.370, in girls and
boys, respectively] levels. However, in the overweight/obese
group, those known to be overweight or obese since the age of
4 were more likely to excrete less U-AGT compared with
those classified as normal weight at the age of 4, with this
difference being significant only in boys (Table 3). This is
indicated by the fact that in boys (but not in girls) who were
overweight/obese at the age of 8–9 years only, a markedly
higher percent of cases was found in the 2nd and 3rd tertiles
of U-AGT, while in boys overweight/obese since the age of 4,
the distribution of cases is relatively homogeneous across the
three U-AGT tertiles (Table 3).
Linear trend analysis showed that the levels of U-H2O2
decreased across P-AGT tertiles in the overweight/obese
group [1st tertile: 1577.0 (959.1–2008.9), 2nd tertile: 1328.9
(701.7–2380.1), 3rd tertile: 846.5 (466.0–1609.4) nmol/day, p
for trend = 0.039] but not in the normal-weight group [1st
tertile: 1007.5 (666.9–2030.7), 2nd tertile: 1323.4 (861.8–
2133.4), 3rd tertile: 1522.2 (704.2–2055.3) nmol/day, p for
trend = 0.548)] Moreover, among overweight/obese children,
the effect of U-H2O2 on P-AGT levels was significant in those
classified as overweight/obese since the age of 4, but not in
those who were not (Fig. 3). The levels of U-H2O2 were sim-
ilar across U-AGT tertiles in children who were overweight/
obese at the age of 8–9; in those who were overweight/obese
since the age of 4, there was a marginally significant (p =
0.053; Fig. 3) decrease of U-H2O2 values across U-AGT
tertiles.
Discussion
Previous studies have shown an increase in U-AGT in chil-
dren with renal disease of different etiologies [16, 38, 39],
namely in adolescents with type 1 diabetes [15] or with pri-
mary hypertension [14], and in children with very low birth
weight [40]. Based on these published data and on the nega-
tive impact that obesity has on the kidney [2], we would ex-
pect that overweight/obese children had higher U-AGT than
age-matched controls of normal weight. However, as recently
reported by our group [36], we observed no significant differ-
ences in U-AGT between normal and overweight/obese chil-
dren. In this study, we further extended this result and clarified
that it is observed regardless of the obesity index considered:
classes of BMI or tertiles of WHtR or percent body fat mass.
Although contrary to our initial hypothesis this result in obese
but otherwise healthy children is in accordance with that of the
only two studies concerning obesity and intrarenal RAAS,
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which reported similar U-AGT between obese and nonobese
adults [7, 18]. In contrast, animal models of obesity show an
imbalance of renal RAAS components. Obese animals have
increased expression of angiotensin-converting enzyme
(ACE) and of AT1 and AT2 receptors, but decreased expres-
sion of ACE2 and Mas receptor [41]. Adipose-derived AGT
determines P-AGT concentration that, by controlling circulat-
ing AngII levels, stimulates proximal tubule production of
AGT [11], thus activating intrarenal RAAS activity.
Although plasma levels of AGT are increased in obese hyper-
tensive compared with nonobese hypertensive patients [42], in
our population, P-AGT was similar between normal and
overweight/obese children, whatever obesity index was con-
sidered. The fact that we found similar levels of U-AGTand P-
AGT might be associated with the duration of obesity (i.e.,
that might be not enough to have a negative impact on kidney
function), activation of slow operating compensatory mecha-
nisms, or both. Interestingly, it has been reported that obesity
severity, duration, and age at onset might be crucial for the
development and progression of obesity-related organ
damage. Using a contemporary population from the
Framingham study, Abdullah et al. suggested that a construct
of obese-years should be preferable to BMI or duration of
obesity alone to estimate the obesity-associated risk of type
2 diabetes [20]. Also, an adolescent onset of obesity was
found to have a stronger impact on diabetes risk than adult-
onset obesity [19]. When we analyzed our group of
overweight/obese children according to the duration of over-
weight/obesity, we observed those with a longer duration pre-
sented lower levels of U-AGT than those with recent offset of
overweight/obesity. This was quite unexpected given that if
renal RAAS progressively contributes to renal damage, along
with the duration of excessive weight, then children already
overweight/obese by the age of 4 would show higher U-AGT.
Some children in our population were identified as being
obese at the age of 4 but as being of normal weight at the
age of 8–9; however, this group was too small to be analyzed.
Interestingly, we previously reported [28] an already lower
eGFR in these overweight/obese children, although renal
function was in the normal range for all children. Also, we
Table 1 General characteristics
of study participants by BMI z-
score classes
BMI z-score classification P value
Normal weight n = 160 Overweight n =
86
Obese n = 59
General characteristics and anthropometry
Age (months) 105.1 ± 3.0 105.2 ± 2.8 105.5 ± 2.8 0.663
Male sex 83 (52%) 43 (50%) 40 (68%) 0.069
Gestational age (weeks) 38.8 ± 1.9 38.9 ± 1.3 38.9 ± 1.2 0.891
Birth weight (g) 3185 ± 483 3266 ± 383 3354 ± 442 0.040
Birth weight for gestational agea 0.923
Small (<10th percentile) 22 (13.8%) 11 (12.8%) 6 (10.2%)
Adequate (10th–90th
percentile)
133 (83.1%) 72 (83.7%) 50 (84.7%)
Large (≥90th percentile) 5 (3.1%) 3 (3.5%) 3 (5.1%)
BMI (kg/m2) 16.0 ± 1.2 19.5 ± 0.9 23.3 ± 2.4 <0.001
Z-score −0.04 ± 0.74 1.56 ± 0.30 2.66 ± 0.49 <0.001
WHtR (cm/m) 44.7 ± 2.6 50.2 ± 3.2 56.6 ± 4.4 <0.001
Percent body fat mass 10.6 ± 7.1 20.0 ± 8.0 27.7 ± 9.4 <0.001
24-h ambulatory BP
24-h MAP (mmHg) 81.1 ± 4.4 82.5 ± 5.2 82.9 ± 6.3 0.030
Z-score 0.35 ± 0.90 0.69 ± 1.07 0.51 ± 0.92 0.032
Daytime MAP (mmHg) 84.8 ± 4.6 85.8 ± 5.8 86.2 ± 6.5 0.157
Z-score 0.06 ± 0.86 0.28 ± 0.96 0.15 ± 0.96 0.219
Nighttime MAP (mmHg) 73.4 ± 4.9 74.8 ± 5.2 75.6 ± 6.3 0.011
Z-score 0.52 ± 0.91 0.85 ± 0.94 0.72 ± 0.79 0.022
MAP dipping (%) 13.4 ± 4.7 12.6 ± 5.2 12.3 ± 4.5 0.212
Nondipping pattern 34 (22%) 30 (35%) 17 (29%) 0.082
Mean ± standard deviation or n (%). BMI z-score classification is according to WHO criteria (normal weight,
overweight, and obesity) [32]
BMI body mass index, WHtR waist-to-height ratio, MAP mean arterial pressure
a According to the population-based Canadian reference curves [30]
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recently reported [36] that urinary excretion of the fibrogenic
cytokines endothelin-1 (ET-1) and transforming growth
factor-β1 (TGF-β1) was not increased in obese children in
our cohort; indeed, they showed lower levels of urinary ET-
1 and TGF-β1 than those of normal weight. Furthermore, U-
AGT was associated with urinary excretion of ET-1 and
TGF-β1 [23]. Of note, although there are reports of human
studies showing increased expression of AGT messenger
RNA (mRNA) in subcutaneous adipose tissue of obese indi-
viduals [43], most human and animal studies report a decrease
[9, 12, 44]. Moreover, expression and secretion of AGT de-
creases as adipocytes become hypertrophied. This effect
seems to be, at least in part, mediated by reactive oxygen
species, namely, H2O2 [12]. Consistent with this, we observed
an inverse association between P-AGT and U-H2O2 in
overweight/obese children but not in normal-weight controls.
Moreover, that association was seen only in children
overweight/obese by the age of 4. So, although further studies
are needed to fully evaluate and characterize this point, our
results suggest that childhood obesity is associated with time-
dependent alterations in intrarenal RAAS activity (even when
established markers of renal function are in the normal range)
and with an association between P-AGT and U-H2O2.
It is noteworthy that the difference observed in U-AGT ac-
cording to duration of obesity was only significant in boys. In
girls, the levels of U-AGTwere not associated with the duration
of overweight/obesity . Studies in animal models suggest that
the kidney has estrogen receptors that can mediate protective
effects against renal injury by attenuating glomerulosclerosis
and tubulointerstitial fibrosis [45, 46]. Interestingly, this protec-
tion has been suggested to involve both the RAAS and the
endothelin system [45]. The children in our study are at a pre-
pubertal age and we were not able to quantify neither Tanner
stages nor sex hormones. As such, although we recruited a
homogeneous population, we cannot conclude whether prepu-
bertal girls already have higher levels of estrogens and andro-
gen metabolites than prepubertal boys, as reported elsewhere
[47, 48]. Moreover, the fact that obesity might anticipate pu-
berty in girls and delay it in boys [49] could somehow blunt the
impact of obesity onU-AGT levels. In other words, the absence
of difference in U-AGTaccording to duration of obesity in girls
could also be explained by the fact that girls in the obese group
were at a more advanced phase of pubertal development. In line
with this, we also observed that boys excreted significantly
more H2O2 than girls (unpublished observations) and that in
boys, higher salt consumption was associated with higher sys-
tolic BP, specifically in those overweight/obese [50].
Major strengths of our study are inclusion of a large and
homogeneous sample of healthy prepubertal children and the
gathering of data on 24-h ABPM and renal function from all
of them. The cross-sectional design of our study might be seen
as a limitation. However, as our cohort will be followed until
adulthood, we expect to re-evaluate these children in the next
evaluation period, when they will be adolescents, and it will
Table 2 Laboratory data by BMI
z-score classes BMI z-score classification P
values
Normal weight
n = 160
Overweight n = 86 Obese n = 59
Blood analytical parameters
Uric acid (mg/dl) 3.5 ± 0.7 3.8 ± 0.7 4.0 ± 0.8 <0.001
Creatinine (mg/dl) 0.43 ± 0.06 0.45 ± 0.06 0.45 ± 0.06 0.003
Cystatin-C (mg/L) 0.64 ± 0.07 0.67 ± 0.08 0.68 ± 0.06 <0.001
eGFR (ml/min/1.73 m2) 138.4 ± 15.8 132.2 ± 16.4 132.1 ± 13.2 0.003
Aldosterone (ng/dl) 9.4 (7.1–13.2) 12.1 (7.5–16.2) 9.6 (8.4–13.8) 0.216
P-AGT (μg/ml)a 36.6 (32.4–47.3) 37.3 (32.6–44.8) 38.8 (34.1–44.3) 0.780
Urinary analytical parameters
U-albumin (mg/g
creatinine)
4.1 (2.6–7.6) 3.6 (2.1–7.8) 3.7 (2.3–5.6) 0.560
U-AGT (μg/g
creatinine)a
5.6 (3.7–7.6) 5.3 (3.4–8.3) 4.8 (2.8–7.8) 0.338
U-H2O2 (nmol/day)
b 1282.0
(711.1–2058.7)
1328.9
(680.5–1988.5)
1276.2
(701.7–2187.2)
0.855
Mean ± standard deviation ormedian (P25–P75). BMI z-score classification is according toWHO criteria (normal
weight, overweight, and obesity) [32]
BMI body mass index, eGFR estimated glomerular filtration rate by Zappitelli combined formula, P-AGT plasma
angiotensinogen, U-albumin urinary albumin-to-creatinine ratio, U-AGT urinary angiotensinogen, U-H2O2 uri-
nary hydrogen peroxide
Data concerningAGT (a ) and H2O2 (
b ) have been recently used by our group as part of studies on the same cohort
intended to evaluate the association with urinary fibrogenic cytokines [36] and oxidative stress [37], respectively
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be possible to perform a longitudinal analysis to complement
and expand the hypothesis raised in this study. In addition,
longitudinal studies should include a group of children that
has experienced weight loss to test whether that would protect
them from metabolic changes later in life.
Our results reinforce the importance of encouraging preven-
tive measures targeting obesity even in prepubertal children,
since obesity seems to have an impact on kidney function even
at this young age. Moreover, data on sex hormones and Tanner
stages would have enriched our analysis significantly.
Fig. 2 Distribution of P-AGTand U-AGT by classes of BMI and tertiles
of waist-to-height ratio and percent body fat mass. Normal weight, over-
weight, and obesity group classification is according to the WHO classi-
fication for BMI z-score [32]. Tertiles of waist-to-height ratio (≤45.65;
45.66–50.00; >50.00) and percent of body fat mass (≤11.10; 11.11–
20.70; >20.70) were divided based on all enrolled participants. P-AGT
and U-AGT data is expressed as medians and percentiles 25 and 75. P
values for linear trend across groups were calculated by linear regression
using U-AGTas dependent variable (logarithm base 10) and adjusting for
sex and age in months. Horizontal dashed lines represent the 25th, 50th,
and 75th percentiles in the normal-weight group for each parameter.
WHOWorld Health Organization, BMI body mass index, P-AGT plasma
angiotensinogen, U-AGT urinary angiotensinogen
Table 3 Distribution of cases
(%) across urinary excretion of
angiotensinogen (U-AGT) tertiles
U-AGT (μg/g creatinine)
1st tertile 2nd tertile 3rd tertile
Boys (p = 0.036)
Overweight/obese since the age of 4 36.7% 34.7% 28.6%
Overweight/obese only at the age of 8–9 11.5% 61.5% 26.9%
Girls (p = 0.383)
Overweight/obese since the age of 4 48.7% 12.8% 38.5%
Overweight/obese only at the age of 8–9 38.9% 27.8% 33.3%
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Alternatively, studies in prepubertal children should be con-
ducted at even youger ages so that the differences in hormonal
levels would not bias the interpretation of the associated results.
Certainly, future analysis by our group will pursue this issue.
In conclusion, although intrarenal RAAS activity in over-
weight and obese children was similar to that of a normal-
weight control group, overweight/obese boys—but not girls—
with a longer duration of obesity presented lower levels of U-
AGT and an inverse association between U-H2O2 and P-AGT.
This might tempt one to think that ACE inhibitors or angioten-
sin receptor bolckers (ARBs) could be less effective in
protecting the kidney of obese patients. However, this study is
Fig. 3 Distribution of U-H2O2 by
tertiles of P-AGT and U-AGT,
according to duration of
overweight/obesity. Tertiles of P-
AGT (≤35.0; 35.0–41.5; >41.5)
and U-AGT (≤4.1; 4.1–6.7; >6.7)
were divided based on all enrolled
participants. U-H2O2 data is
expressed as medians and
percentiles 25 and 75.P values for
linear trend across groups were
calculated by linear regression
using U-H2O2 as dependent
variable (logarithm base 10) and
adjusting for sex and age in
months. WHOWorld Health
Organization, BMI body mass
index, U-H2O2 urinary hydrogen
peroxide, P-AGT plasma
angiotensinogen, U-AGT urinary
angiotensinogen
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the first to address the role of the RAAS in the context of
obesity-induced renal damage. Also, it focused on short-lasting,
early childhood obesity, which might not have the same conse-
quences as chronic obesity. Therefore, further studies are essen-
tial (including longitudinal studies) to support evidenced-based
guidelines for obese patients, since this population has only
been addressed in expert opinion and not in actual guidelines.
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